Soulmates Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Antiverse secures £7m Series A led by Soulmates Ventures for AI-designed antibodies targeting undruggable diseases
Antiverse develops therapeutic antibodies designed using machine learning and built in its own laboratories. It generates and tests antibody candidates against difficult disease targets, including membrane proteins, for pharmaceutical and foundation partners.
Rightcharge secures £1.6m seed round led by Soulmates Ventures to simplify EV charging data for Europe's fleets
Rightcharge provides a payments platform for electric vehicle fleets that automates home charging reimbursements and consolidates public charging costs, linking directly to energy accounts to reduce admin, errors and charging expenses for businesses.
Signapse closes £2m seed round to accelerate accessibility for deaf people
Signapse builds generative AI software that translates written and spoken English into sign language, improving accessibility by enabling scalable, video-based communication for Deaf users across digital and physical environments.
More venture news
- 12 Aug 2026
MindgardMindgard secures £22m Series A led by Album VC to test and defend AI systems against adversarial attack
Series ACybersecurity - 12 Aug 2026
CytixCytix raises a £5m Series A round led by Northern Gritstone to manage the security risk of AI-driven software change
Series ACybersecurity - 29 Jul 2026
LemonEdgeLemonEdge announced £16m Series A round led by Blackstone Innovations Investments for a fund accounting platform built for private markets
Series AFintech
